Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

Share:
More In Business
Cybersecurity is Entering a New Era
Jim Guinn, EY Americas Cybersecurity Leader, shares how companies must stay vigilant and navigate the evolving regulatory landscape. *Sponsored by EY
Load More